Roche and reMYND Enter Agreement to Develop First-in-Class Disease-Modifying Treatments for Parkinson’s and Alzheimer’s Disease 07 September 2010 Novel therapies to target unmet needs in neurodegenerative disorders.
Novozymes Announces Master File for Recombinant Albumin 03 September 2010 The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.
Key Bio Nano Consulting Partner Develops Nanolitre Scale Technique for Determining Protein Stability and Ligand-Binding Affinity 26 August 2010 BNC to provide commercial access to new technique enabling evaluation of low expressing proteins without the need for fluorescent tags.
Nature Medicine Publishes AVI BioPharma Preclinical Studies 25 August 2010 Study demonstrates post-exposure efficacy of PMOplus™ Oligomers against Ebola and Marburg Viruses.
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics 20 August 2010 The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Clavis Recruits First Patient in Pivotal Phase III Study of Elacytarabine in Late-Stage Acute Myeloid Leukaemia 19 August 2010 Clinical trial aims to confirm significant survival benefit seen in Phase II.
Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems 19 August 2010 The applications submitted to USPTO relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
NoAb BioDiscoveries and VigiCell Enter into a Collaboration and Co-Distribution Agreement 19 August 2010 The companies have signed an agreement in principle to collaborate and co-distribute each other’s complementary drug discovery services.
Santhera Obtains European Patent for Use of Catena®/Sovrima® 18 August 2010 Patent covers the treatment or prevention of weakness and loss of skeletal muscle tissue including Duchenne Muscular Dystrophy and other muscular dystrophies.
Stem Cell Therapeutics Corp: Traumatic Brain Injury Clinical Study Gains IRB Approval at University of Calgary 18 August 2010 The study is a single center open label study to characterize the safety of hCG and EPO in traumatic brain injury patients.
The R&D Leaders Band Together for a Common Goal: Discovery of Life-saving Treatment 18 August 2010 Marcus Evans, the producer of high-level business events for the world’s leading business decision-makers, has announced The Discovery Summit 2010, taking place from 19-21 September 2010 in Las Vegas, NV, USA.
Amarin’s Amr101 Pivotal Phase 3 Marine Clinical Trial Completes Patient Enrollment and Randomization 11 August 2010 The Company announced that top line results from the trial are expected early in 2011.
Algeta Announces First Cancer Patient Treated in Phase I/IIa Trial Of Alpharadin in Combination with Docetaxel Chemotherapy 11 August 2010 Combination study offers potential to extend Alpharadin use to prostate cancer patients who can tolerate chemotherapy.